高级搜索
p53、p21wafl和PCNA诊断肺癌价值研究[J]. 肿瘤防治研究, 2000, 27(06): 457-459. DOI: 10.3971/j.issn.1000-8578.1215
引用本文: p53、p21wafl和PCNA诊断肺癌价值研究[J]. 肿瘤防治研究, 2000, 27(06): 457-459. DOI: 10.3971/j.issn.1000-8578.1215
Analysis of the Value of p53,p21wafl,and PCNA for Lung Cancer Diagnosis[J]. Cancer Research on Prevention and Treatment, 2000, 27(06): 457-459. DOI: 10.3971/j.issn.1000-8578.1215
Citation: Analysis of the Value of p53,p21wafl,and PCNA for Lung Cancer Diagnosis[J]. Cancer Research on Prevention and Treatment, 2000, 27(06): 457-459. DOI: 10.3971/j.issn.1000-8578.1215

p53、p21wafl和PCNA诊断肺癌价值研究

Analysis of the Value of p53,p21wafl,and PCNA for Lung Cancer Diagnosis

  • 摘要: 目的 筛选肺癌诊断标志物。方法 运用病例—对照研究, 评价p53、p2 1wafl及PCNA蛋白诊断肺癌价值。结果  ( 1)肺癌p53、p2 1wafl及PCNA蛋白表达阳性率均明显高于慢性肺良性疾病。 ( 2 )p53蛋白诊断肺癌的阳性似然比为 13 97,其特异度显著高于p2 1wafl和PCNA。 ( 3)p53阴性者联合p2 1wafl和PCNA平行试验的阴性似然比为 0 10 5。结论  ( 1)肺癌p53、p2 1wafl和PC NA蛋白表达上调, 三者均与肺癌有很强联系。 ( 2 )p53是较好的肺癌诊断单项指标。三项蛋白表达均为阴性时, 倾向于排除肺癌诊断。

     

    Abstract: Objective To seek potential biomarkers for lung cancer diagnosis. Methods The expression status of p53,p21wafl and PCNA in lung cancer and benign pulmonary diseases were studied and the diagnostic value of these three markers was analysed by case-control study. Results (1) The positive rates of p53,p21 wafl and PCNA expression in lung cancer were all significantly higher than those in benign pulmonary diseases.(2) The positive likelihood ratio of p53 was 13.97.Its specificity was significantly higher than tha...

     

/

返回文章
返回